Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.

@article{Nelson2000FluticasonePC,
  title={Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast.},
  author={H. Stanley Nelson and William W. Busse and Edward M. Kerwin and Nicholas Church and A. J. J. Emmett and Kathleen Rickard and Katharine Knobil},
  journal={The Journal of allergy and clinical immunology},
  year={2000},
  volume={106 6},
  pages={1088-95}
}
BACKGROUND Asthma is a disease of chronic inflammation and bronchoconstriction. Inhaled corticosteroids (ICSs) provide important anti-inflammatory treatment but may not provide optimal control of asthma when taken alone. Two therapeutic alternatives for enhanced asthma control are to substitute the combination of fluticasone propionate (FP) and salmeterol (FP/Salm Combo) through the Diskus inhaler or to add montelukast to existing ICS therapy. OBJECTIVE We compared the efficacy and safety of… CONTINUE READING